Alphatec Holdings Inc  

(Public, NASDAQ:ATEC)   Watch this stock  
Find more results for ATEC
1.95
+0.03 (1.56%)
May 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 1.89 - 1.95
52 week 1.41 - 2.40
Open 1.93
Vol / Avg. 58,069.00/206,338.00
Mkt cap 188.53M
P/E     -
Div/yield     -
EPS -0.18
Shares 96.68M
Beta 1.74
Inst. own 66%
Aug 5, 2013
Q2 2013 ALPHATEC HOLDINGS INC Earnings Release Add to calendar
Jun 17, 2013
ALPHATEC HOLDINGS INC Annual Shareholder Meeting - 5:00PM EDT - Add to calendar
Jun 6, 2013
ALPHATEC HOLDINGS INC Technology Day - 8:30AM EDT - Add to calendar
May 14, 2013
ALPHATEC HOLDINGS INC at Bank of America Merrill Lynch Health Care Conference
May 6, 2013
Q1 2013 ALPHATEC HOLDINGS INC Earnings Release
Apr 30, 2013
Q1 2013 ALPHATEC HOLDINGS INC Earnings Conference Call
Mar 19, 2013
ALPHATEC HOLDINGS INC at Canaccord Genuity Musculoskeletal Conference
Feb 28, 2013
Q4 2012 ALPHATEC HOLDINGS INC Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -5.25% -7.88%
Operating margin -2.69% -5.01%
EBITD margin - 7.11%
Return on average assets -2.81% -4.13%
Return on average equity -4.38% -6.30%
Employees 490 -
Carbon Disclosure Rating - -

Address

5818 El Camino Real
CARLSBAD, CA 92008
United States - Map
+1-760-4319286 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Alphatec Holdings, Inc. (Alphatec) is a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. The Company has product portfolio and pipelines that addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a variety of spinal disorders and procedures. The Company's principal product offerings are focused on the worldwide market for orthopedic spinal disorder solutions. The Company's principal product offering includes a variety of spinal implant products and systems consisted of components, such as spine screws and rods, spinal spacers, plates, and various biologics offerings. In addition, outside of the United States, the Company sells solutions for treating vertebral compression fractures and spinal stenosis.

Officers and directors

Leslie H. Cross Chairman of the Board, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Michael O'Neill Chief Financial Officer, Vice President, Treasurer
Age: 51
Bio & Compensation  - Reuters
Mitsuo Asai President of Alphatec Pacific, Inc.
Age: 54
Bio & Compensation  - Reuters
William Patrick Ryan Chief Operating Officer
Bio & Compensation  - Reuters
Ebun S. Garner Esq. Senior Vice President, General Counsel, Secretary
Age: 40
Bio & Compensation  - Reuters
Curt Jennewine Senior Vice President - Global Marketing, Asia Pacific
Age: 44
Bio & Compensation  - Reuters
Heather Rider Senior Vice President - Global Human Resources
Age: 52
Bio & Compensation  - Reuters
Thomas McLeer Senior Vice President - U.S. Commercial Operations
Bio & Compensation  - Reuters
Michael Plunkett Vice President - Operations
Bio & Compensation  - Reuters
Stephen Lubischer Vice President - Sales
Age: 49
Bio & Compensation  - Reuters